Catalyst Wire Dossier Catalyst Wire Dossier

Nefecon

nefecon · Calliditas Therapeutics AB
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Nefecon, covering 2015-09-24 to 2025-09-15. Get the full timeline:

Most recent: Clinical Trial Update: Nefecon and Ambrisentan in IgA Nephropathy [Phase 4]

See pricing